# Clinical Trial of Ventiflow LP Supporting High-risk Percutaneous Coronary Intervention(PCI)

> **NCT06754839** · NA · NOT_YET_RECRUITING · sponsor: **Suzhou Hearthill Medical Technology Co.,LTD** · enrollment: 250 (estimated)

## Conditions studied

- Coronary Artery Disease
- Heart Failure
- High-risk PCI

## Interventions

- **DEVICE:** Percutaneous left ventricular assist device(Ventiflow LP)
- **DEVICE:** VA-ECMO

## Key facts

- **NCT ID:** NCT06754839
- **Lead sponsor:** Suzhou Hearthill Medical Technology Co.,LTD
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-12
- **Primary completion:** 2025-10
- **Final completion:** 2025-12
- **Target enrollment:** 250 (ESTIMATED)
- **Last updated:** 2025-01-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06754839

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06754839, "Clinical Trial of Ventiflow LP Supporting High-risk Percutaneous Coronary Intervention(PCI)". Retrieved via AI Analytics 2026-09-21 from https://api.ai-analytics.org/clinical/NCT06754839. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*